74 related articles for article (PubMed ID: 24251463)
21. Correlation between biological activity and binding energy in systems of integrin with cyclic RGD-containing binders: a QM/MM molecular dynamics study.
Xiang M; Lin Y; He G; Chen L; Yang M; Yang S; Mo Y
J Mol Model; 2012 Nov; 18(11):4917-27. PubMed ID: 22736220
[TBL] [Abstract][Full Text] [Related]
22. Discrete functional motifs reside within the cytoplasmic tail of alphaV integrin subunit.
Haas TA
Thromb Haemost; 2008 Jan; 99(1):96-107. PubMed ID: 18217140
[TBL] [Abstract][Full Text] [Related]
23. Mouse recombinant protein C variants with enhanced membrane affinity and hyper-anticoagulant activity in mouse plasma.
Krisinger MJ; Guo LJ; Salvagno GL; Guidi GC; Lippi G; Dahlbäck B
FEBS J; 2009 Nov; 276(22):6586-602. PubMed ID: 19817854
[TBL] [Abstract][Full Text] [Related]
24. Activated protein C-protein C inhibitor complex formation: characterization of a neoepitope provides evidence for extensive insertion of the reactive center loop.
Strandberg K; Kjellberg M; Erb EM; Persson U; Mosher DF; Villoutreix BO; Stenflo J
Biochemistry; 2000 Dec; 39(51):15713-20. PubMed ID: 11123896
[TBL] [Abstract][Full Text] [Related]
25. Cytoplasmic salt bridge formation in integrin αvß3 stabilizes its inactive state affecting integrin-mediated cell biological effects.
Müller MA; Brunie L; Bächer AS; Kessler H; Gottschalk KE; Reuning U
Cell Signal; 2014 Nov; 26(11):2493-503. PubMed ID: 25041847
[TBL] [Abstract][Full Text] [Related]
26. Zinc ions bind to and inhibit activated protein C.
Zhu T; Ubhayasekera W; Nickolaus N; Sun W; Tingsborg S; Mowbray SL; Schedin-Weiss S
Thromb Haemost; 2010 Sep; 104(3):544-53. PubMed ID: 20664913
[TBL] [Abstract][Full Text] [Related]
27. Protein C Sapporo (protein C Glu 25 --> Lys): a heterozygous missense mutation in the Gla domain provides new insight into the interaction between protein C and endothelial protein C receptor.
Nakabayashi T; Mizukami K; Naitoh S; Takeda M; Shikamoto Y; Nakagawa T; Kaneko H; Tarumi T; Mizoguchi I; Mizuno H; Ieko M; Koike T
Thromb Haemost; 2005 Nov; 94(5):942-50. PubMed ID: 16363234
[TBL] [Abstract][Full Text] [Related]
28. Molecular dynamics simulations of forced unbending of integrin α(v)β₃.
Chen W; Lou J; Hsin J; Schulten K; Harvey SC; Zhu C
PLoS Comput Biol; 2011 Feb; 7(2):e1001086. PubMed ID: 21379327
[TBL] [Abstract][Full Text] [Related]
29. Fluorometric assay of integrin activity with a small-molecular probe that senses the binding site microenvironment.
Komatsu T; Takeda A; Hanaoka K; Terai T; Ueno T; Tada Y; Nagano T; Urano Y
Chem Commun (Camb); 2014 Dec; 50(100):15894-6. PubMed ID: 25376090
[TBL] [Abstract][Full Text] [Related]
30. Molecular dynamics simulations to the bidirectional adhesion signaling pathway of integrin α
Kulke M; Langel W
Proteins; 2020 May; 88(5):679-688. PubMed ID: 31693219
[TBL] [Abstract][Full Text] [Related]
31. Engineering a disulfide bond to stabilize the calcium-binding loop of activated protein C eliminates its anticoagulant but not its protective signaling properties.
Bae JS; Yang L; Manithody C; Rezaie AR
J Biol Chem; 2007 Mar; 282(12):9251-9. PubMed ID: 17255099
[TBL] [Abstract][Full Text] [Related]
32. Screening the molecular surface of human anticoagulant protein C: a search for interaction sites.
Villoutreix BO; Covell DG; Blom AM; Wallqvist A; Friedrich U; Dahlbäck B
J Comput Aided Mol Des; 2001 Jan; 15(1):13-27. PubMed ID: 11219426
[TBL] [Abstract][Full Text] [Related]
33. Exploration of the chlorpyrifos escape pathway from acylpeptide hydrolases using steered molecular dynamics simulations.
Wang D; Jin H; Wang J; Guan S; Zhang Z; Han W
J Biomol Struct Dyn; 2016; 34(4):749-61. PubMed ID: 26155973
[TBL] [Abstract][Full Text] [Related]
34. In silico studies, synthesis and binding evaluation of substituted 2-pyrrolidinones as peptidomimetics of RGD tripeptide sequence.
Toum V; Bolley J; Lalatonne Y; Barbey C; Motte L; Lecouvey M; Royer J; Dupont N; Pérard-Viret J
Eur J Med Chem; 2015 Mar; 93():360-72. PubMed ID: 25721024
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of photocaged RGDS peptides for cell patterning.
Goubko CA; Basak A; Majumdar S; Jarrell H; Khieu NH; Cao X
J Biomed Mater Res A; 2013 Mar; 101(3):787-96. PubMed ID: 22961935
[TBL] [Abstract][Full Text] [Related]
36. Low Stability of Integrin-Binding Deficient Mutant of FGF1 Restricts Its Biological Activity.
Szlachcic A; Sochacka M; Czyrek A; Opalinski L; Krowarsch D; Otlewski J; Zakrzewska M
Cells; 2019 Aug; 8(8):. PubMed ID: 31443196
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms Contributing to Acquired Activated Protein C Resistance in Patients Treated with Thalidomide: A Molecular Dynamics Study.
Maximiliano CL; Jaime GC; Armando VL; Vega IL; Victoria HG; Erika MH
Cardiovasc Hematol Disord Drug Targets; 2023; 22(4):237-244. PubMed ID: 36694314
[TBL] [Abstract][Full Text] [Related]
38. Design and characterization of novel activated protein C variants for the proteolysis of cytotoxic extracellular histone H3.
Huckriede JB; Beurskens DMH; Wildhagen KCCA; Reutelingsperger CPM; Wichapong K; Nicolaes GAF
J Thromb Haemost; 2023 Dec; 21(12):3557-3567. PubMed ID: 37657561
[TBL] [Abstract][Full Text] [Related]
39. A molecular model of the serine protease domain of activated protein C: application to the study of missense mutations causing protein C deficiency.
Wacey AI; Pemberton S; Cooper DN; Kakkar VV; Tuddenham EG
Br J Haematol; 1993 Jun; 84(2):290-300. PubMed ID: 8398833
[TBL] [Abstract][Full Text] [Related]
40. NMR and computational methods in the structural and dynamic characterization of ligand-receptor interactions.
Ghitti M; Musco G; Spitaleri A
Adv Exp Med Biol; 2014; 805():271-304. PubMed ID: 24446366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
